These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33359578)

  • 1. A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®.
    Bircsak KM; DeBiasio R; Miedel M; Alsebahi A; Reddinger R; Saleh A; Shun T; Vernetti LA; Gough A
    Toxicology; 2021 Feb; 450():152667. PubMed ID: 33359578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of reproducibility and robustness of OrganoPlate® 2-lane 96, a liver microphysiological system for studies of pharmacokinetics and toxicological assessment of drugs.
    Kato Y; Lim AY; Sakolish C; Valdiviezo A; Moyer HL; Hewitt P; Bajaj P; Han G; Rusyn I
    Toxicol In Vitro; 2022 Dec; 85():105464. PubMed ID: 36057418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of reproducibility and robustness of a human microfluidic four-cell liver acinus microphysiology system (LAMPS).
    Sakolish C; Reese CE; Luo YS; Valdiviezo A; Schurdak ME; Gough A; Taylor DL; Chiu WA; Vernetti LA; Rusyn I
    Toxicology; 2021 Jan; 448():152651. PubMed ID: 33307106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
    Ware BR; Berger DR; Khetani SR
    Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically induced hepatotoxicity in human stem cell-induced hepatocytes compared with primary hepatocytes and HepG2.
    Kang SJ; Lee HM; Park YI; Yi H; Lee H; So B; Song JY; Kang HG
    Cell Biol Toxicol; 2016 Oct; 32(5):403-17. PubMed ID: 27287938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.
    Grimm FA; Iwata Y; Sirenko O; Bittner M; Rusyn I
    Assay Drug Dev Technol; 2015 Nov; 13(9):529-46. PubMed ID: 26539751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
    Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
    Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-D culture and endothelial cells improve maturity of human pluripotent stem cell-derived hepatocytes.
    Ardalani H; Sengupta S; Harms V; Vickerman V; Thomson JA; Murphy WL
    Acta Biomater; 2019 Sep; 95():371-381. PubMed ID: 31362140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis.
    Sirenko O; Hancock MK; Hesley J; Hong D; Cohen A; Gentry J; Carlson CB; Mann DA
    Assay Drug Dev Technol; 2016 Sep; 14(7):381-94. PubMed ID: 27494736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of human iPSC-derived hepatocyte phenotype via extracellular matrix microarrays.
    Monckton CP; Brougham-Cook A; Underhill GH; Khetani SR
    Acta Biomater; 2022 Nov; 153():216-230. PubMed ID: 36115650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microfluidic 3D hepatocyte chip for hepatotoxicity testing of nanoparticles.
    Li L; Gokduman K; Gokaltun A; Yarmush ML; Usta OB
    Nanomedicine (Lond); 2019 Aug; 14(16):2209-2226. PubMed ID: 31179822
    [No Abstract]   [Full Text] [Related]  

  • 12. Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays.
    Nakamura N; Saeki K; Mitsumoto M; Matsuyama S; Nishio M; Saeki K; Hasegawa M; Miyagawa Y; Ohkita H; Kiyokawa N; Toyoda M; Akutsu H; Umezawa A; Yuo A
    Cell Reprogram; 2012 Apr; 14(2):171-85. PubMed ID: 22384928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput metabolism-induced toxicity assays demonstrated on a 384-pillar plate.
    Yu KN; Kang SY; Hong S; Lee MY
    Arch Toxicol; 2018 Aug; 92(8):2501-2516. PubMed ID: 29974144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel evaluation method for determining drug-induced hepatotoxicity using 3D bio-printed human liver tissue.
    Ide I; Nagao E; Kajiyama S; Mizoguchi N
    Toxicol Mech Methods; 2020 Mar; 30(3):189-196. PubMed ID: 31736396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.
    Wang B; Jakus AE; Baptista PM; Soker S; Soto-Gutierrez A; Abecassis MM; Shah RN; Wertheim JA
    Stem Cells Transl Med; 2016 Sep; 5(9):1257-67. PubMed ID: 27421950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of Hepatotoxicity in iPSC-Derived Hepatocytes by Multiplexed High Content Assays.
    Sirenko O; Cromwell EF
    Methods Mol Biol; 2018; 1683():339-354. PubMed ID: 29082501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Hepatic Functions of Genetically Modified Mouse Hepatoma Cells by Spheroid Culture for Drug Toxicity Screening.
    Sarkar J; Kumari J; Tonello JM; Kamihira M; Kumar A
    Biotechnol J; 2017 Oct; 12(10):. PubMed ID: 28834334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform.
    Lanz HL; Saleh A; Kramer B; Cairns J; Ng CP; Yu J; Trietsch SJ; Hankemeier T; Joore J; Vulto P; Weinshilboum R; Wang L
    BMC Cancer; 2017 Nov; 17(1):709. PubMed ID: 29096610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.
    Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL
    Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.